GLP-1 Receptor Agonists Complete Guide: Mechanisms, Types, Research & Applications (2026) Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the treatment of type 2 diabetes and obesity, and are now being investigated for a wide range of other conditions including cardiovascular disease, neurodegenerative disorders, non-alcoholic steatohepatitis (NASH), and more. This comprehensive guide examines the GLP-1 receptor […]
Tag Archives: Tirzepatide
Tirzepatide Complete Research Guide: The GIP/GLP-1 Dual Agonist (2026) Tirzepatide (marketed as Mounjaro for type 2 diabetes and Zepbound for obesity) has become one of the most studied metabolic peptides in modern pharmaceutical research. As the first dual agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, it represents a significant advancement […]
Tirzepatide vs Semaglutide: Complete Comparison Guide for Research (2026) The metabolic peptide research landscape has been transformed by two remarkable molecules: tirzepatide and semaglutide. Both have generated enormous interest in research communities worldwide, yet they operate through fundamentally different mechanisms. This comprehensive guide compares these two peptides across mechanism of action, receptor pharmacology, research outcomes, […]
——–|————-|————-|————-| GLP-1 receptor ✓ Strong ✓ Strong ✓ Strong GIP receptor ✗ ✓ Strong ✓ Moderate Glucagon receptor ✗ ✗ ✓ Moderate Insulin secretion ✓ ✓✓ ✓✓ Appetite suppression ✓✓ ✓✓ ✓✓✓ Gastric emptying ✓✓ ✓ ✓ Energy expenditure ✗ ✗ ✓✓ Fat oxidation ✗ ✓ ✓✓ Liver fat reduction ✓ ✓✓ ✓✓✓ Efficacy and […]